Back to Search
Start Over
MET Exon 14 Alterations in Lung Cancer: Exon Skipping Extends Half-Life
- Source :
- Clinical Cancer Research. 22:2832-2834
- Publication Year :
- 2016
- Publisher :
- American Association for Cancer Research (AACR), 2016.
-
Abstract
- MET exon 14 alterations are a diverse group of mutations, many of which disrupt splice acceptor or donor sites leading to exon 14 skipping, impaired receptor degradation, and oncogenic transformation. These alterations are clinically targetable with MET-directed therapy. Clin Cancer Res; 22(12); 2832–4. ©2016 AACR. See related article by Tong et al., p. 3048
- Subjects :
- 0301 basic medicine
Cancer Research
Lung Neoplasms
Article
03 medical and health sciences
Exon
0302 clinical medicine
Carcinoma, Non-Small-Cell Lung
Carcinoma
medicine
Humans
splice
Lung cancer
business.industry
Extramural
Exons
Proto-Oncogene Proteins c-met
medicine.disease
Molecular biology
Exon skipping
Alternative Splicing
030104 developmental biology
Oncology
030220 oncology & carcinogenesis
business
Receptor degradation
Subjects
Details
- ISSN :
- 15573265 and 10780432
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- Clinical Cancer Research
- Accession number :
- edsair.doi.dedup.....8076078714e85356a9adee2574a153e2